/Charles%20River%20Laboratories%20International%20Inc_%20chart%20and%20logo-by%20IgorGolovniov%20via%20Shutterstock.jpg)
Wilmington, Massachusetts-based Charles River Laboratories International, Inc. (CRL) provides drug discovery, non-clinical development, and safety testing services. Valued at $9.5 billion by market cap, the company offers animal research models in research and development for new drugs, devices, and therapies, serving pharmaceutical and biotechnology companies, hospitals, and academic institutions worldwide.
Companies worth $2 billion or more are generally described as “mid-cap stocks,” and CRL fits right into that category with its market cap exceeding this threshold, reflecting its substantial size, influence, and dominance in the diagnostics & research industry. With a history dating back to 1947, the company is a leader in providing animal models for laboratory testing, solidifying its position as a one-stop-shop for pharmaceutical and biotechnology companies. CRL's reputation for quality and reliability has made it a trusted partner in the highly regulated pharmaceutical industry.
